Job Details
Location:
Dassault Systems, 20, Joseph-Wild-Straße, Bezirksteil Messestadt Riem, Stadtbezirk 15 Trudering-Riem, Munich, Bavaria, 81829, Germany
Dassault Systems, 20, Joseph-Wild-Straße, Bezirksteil Messestadt Riem, Stadtbezirk 15 Trudering-Riem, Munich, Bavaria, 81829, Germany
Posted:
Oct 26, 2019
Job Description
Req #: 1802918
Location: Munich, Germany
Job Category: Human Resources
Work Location: Joseph-Wild-Strasse 20 81829
Organization: Intern
Employee Status: Part-time
Job Type: Fixed_Term
Responsibilities include, but are not limited to:
Support of the Marketing Team:
1. Managing competitors’ materials
2. Analysis of competitors' materials (sales aids, congress activities, websites etc.) & documentation of advertising slogans and key messages
3. Creating a quarterly report for the back office and field force
General support:
4. Support in development/maintenance of websites
5. Entering contracts in Oracle
6. Filing and sending documents
7. Creating Vendors
8. Support in the creation of travel expenses
9. Optimize the storage system of the filed contracts
10. Requesting and reservation of hotels and restaurants for meetings
Skills/Knowledge Required:
- Strong identification with the values of Celgene
- Enrolled student in the natural sciences, business administration or similar
- Interest in the German pharmaceutical market
- Interest and understanding of advertising
- Good to excellent Excel and PowerPoint skills
- Good understanding of IT approaches and skills
- Team player
- Precise way of working
- Fluency in German and English
#LI-EX
About UsCOMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.